Pharmaceutical Approval Update August 2018  P&T Community

Manufacturer: US WorldMeds LLC, Louisville, Kentucky. Date of Approval: May 16, 2018. Indication: Lofexidine is a central alpha-2 adrenergic agonist indicated …

X